Cargando…
Primary tracheobronchial mucoepidermoid carcinoma - a retrospective study of 32 patients
BACKGROUND: This retrospective study was designed to investigate the clinical characteristics, diagnosis, treatment and prognosis of primary tracheobronchial mucoepidermoid carcinoma (MEC). METHODS: Clinical data were retrospectively analyzed from 32 patients with pathologically confirmed primary tr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599790/ https://www.ncbi.nlm.nih.gov/pubmed/23497031 http://dx.doi.org/10.1186/1477-7819-11-62 |
_version_ | 1782475530618011648 |
---|---|
author | Song, Zhengbo Liu, Zhuo Wang, Jiwen Zhu, Huineng Zhang, Yiping |
author_facet | Song, Zhengbo Liu, Zhuo Wang, Jiwen Zhu, Huineng Zhang, Yiping |
author_sort | Song, Zhengbo |
collection | PubMed |
description | BACKGROUND: This retrospective study was designed to investigate the clinical characteristics, diagnosis, treatment and prognosis of primary tracheobronchial mucoepidermoid carcinoma (MEC). METHODS: Clinical data were retrospectively analyzed from 32 patients with pathologically confirmed primary tracheobronchial MEC between January 1990 and December 2010 at Zhejiang Cancer Hospital. The Kaplan-Meier methods were used to estimate and compare survival rates. RESULTS: There were 19 males and 13 females ranging in age from 7 to 73 years, with a median age of 28 years. Twenty-six of the 32 patients were treated with surgery alone. The other six patients were treated with surgery plus postoperative radiotherapy or chemotherapy. Six patients died during the follow-up time. The overall five-year survival rates were 81.25%, whereas the five-year survival rate of seven patients with high-grade tumors was only 28.6%. Stage I and II patients experienced better survival than Stage III and IV patients (the five-year survival rate was 100% and 43.6% respectively, P<0.001). CONCLUSIONS: Primary tracheobronchial MEC is a rare disease. Histologic grading and TNM (tumor-node-metastasis)staging are independent prognostic factors. Surgical resection is the primary treatment. |
format | Online Article Text |
id | pubmed-3599790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35997902013-03-17 Primary tracheobronchial mucoepidermoid carcinoma - a retrospective study of 32 patients Song, Zhengbo Liu, Zhuo Wang, Jiwen Zhu, Huineng Zhang, Yiping World J Surg Oncol Research BACKGROUND: This retrospective study was designed to investigate the clinical characteristics, diagnosis, treatment and prognosis of primary tracheobronchial mucoepidermoid carcinoma (MEC). METHODS: Clinical data were retrospectively analyzed from 32 patients with pathologically confirmed primary tracheobronchial MEC between January 1990 and December 2010 at Zhejiang Cancer Hospital. The Kaplan-Meier methods were used to estimate and compare survival rates. RESULTS: There were 19 males and 13 females ranging in age from 7 to 73 years, with a median age of 28 years. Twenty-six of the 32 patients were treated with surgery alone. The other six patients were treated with surgery plus postoperative radiotherapy or chemotherapy. Six patients died during the follow-up time. The overall five-year survival rates were 81.25%, whereas the five-year survival rate of seven patients with high-grade tumors was only 28.6%. Stage I and II patients experienced better survival than Stage III and IV patients (the five-year survival rate was 100% and 43.6% respectively, P<0.001). CONCLUSIONS: Primary tracheobronchial MEC is a rare disease. Histologic grading and TNM (tumor-node-metastasis)staging are independent prognostic factors. Surgical resection is the primary treatment. BioMed Central 2013-03-09 /pmc/articles/PMC3599790/ /pubmed/23497031 http://dx.doi.org/10.1186/1477-7819-11-62 Text en Copyright ©2013 Song et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Song, Zhengbo Liu, Zhuo Wang, Jiwen Zhu, Huineng Zhang, Yiping Primary tracheobronchial mucoepidermoid carcinoma - a retrospective study of 32 patients |
title | Primary tracheobronchial mucoepidermoid carcinoma - a retrospective study of 32 patients |
title_full | Primary tracheobronchial mucoepidermoid carcinoma - a retrospective study of 32 patients |
title_fullStr | Primary tracheobronchial mucoepidermoid carcinoma - a retrospective study of 32 patients |
title_full_unstemmed | Primary tracheobronchial mucoepidermoid carcinoma - a retrospective study of 32 patients |
title_short | Primary tracheobronchial mucoepidermoid carcinoma - a retrospective study of 32 patients |
title_sort | primary tracheobronchial mucoepidermoid carcinoma - a retrospective study of 32 patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599790/ https://www.ncbi.nlm.nih.gov/pubmed/23497031 http://dx.doi.org/10.1186/1477-7819-11-62 |
work_keys_str_mv | AT songzhengbo primarytracheobronchialmucoepidermoidcarcinomaaretrospectivestudyof32patients AT liuzhuo primarytracheobronchialmucoepidermoidcarcinomaaretrospectivestudyof32patients AT wangjiwen primarytracheobronchialmucoepidermoidcarcinomaaretrospectivestudyof32patients AT zhuhuineng primarytracheobronchialmucoepidermoidcarcinomaaretrospectivestudyof32patients AT zhangyiping primarytracheobronchialmucoepidermoidcarcinomaaretrospectivestudyof32patients |